Trial
NCT02187029
Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Gout
Intervention
PF-06743649
Why stopped
B7911002 was prematurely discontinued due to a safety concern that led to decision to terminate the study on 10 Nov 2014
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-11-11